Phreesia (NYSE:PHR) Hits New 1-Year Low – Should You Sell?

Phreesia, Inc. (NYSE:PHR)’s stock price reached a new 52-week low during trading on Tuesday . The stock traded as low as $15.09 and last traded at $15.03, with a volume of 100210 shares traded. The stock had previously closed at $15.72.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. JPMorgan Chase & Co. decreased their price target on shares of Phreesia from $32.00 to $29.00 and set an “overweight” rating for the company in a research note on Tuesday, December 9th. Canaccord Genuity Group reduced their target price on Phreesia from $38.00 to $33.00 and set a “buy” rating on the stock in a report on Tuesday, December 9th. Truist Financial set a $24.00 target price on Phreesia in a research note on Thursday, January 8th. Citigroup dropped their price target on Phreesia from $29.00 to $25.00 and set a “buy” rating on the stock in a research report on Friday, January 9th. Finally, DA Davidson reduced their price target on Phreesia from $35.00 to $30.00 and set a “buy” rating on the stock in a research note on Friday. Seventeen equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $29.76.

Phreesia Stock Performance

The company has a current ratio of 2.44, a quick ratio of 2.44 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $893.20 million, a P/E ratio of -148.40 and a beta of 0.61. The business’s 50 day simple moving average is $17.59 and its two-hundred day simple moving average is $22.72.

Phreesia (NYSE:PHR) last issued its earnings results on Monday, December 8th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.11. The firm had revenue of $120.33 million for the quarter, compared to the consensus estimate of $119.98 million. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The business’s revenue was up 12.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.25) earnings per share. Sell-side analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Insider Buying and Selling at Phreesia

In other Phreesia news, General Counsel Allison C. Hoffman sold 3,995 shares of Phreesia stock in a transaction on Friday, January 16th. The stock was sold at an average price of $16.36, for a total value of $65,358.20. Following the completion of the sale, the general counsel owned 169,661 shares of the company’s stock, valued at approximately $2,775,653.96. This trade represents a 2.30% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Evan Roberts sold 6,268 shares of the company’s stock in a transaction on Friday, January 16th. The shares were sold at an average price of $16.36, for a total value of $102,544.48. Following the transaction, the insider directly owned 826,554 shares in the company, valued at approximately $13,522,423.44. The trade was a 0.75% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 60,766 shares of company stock worth $1,013,817. Insiders own 5.50% of the company’s stock.

Institutional Trading of Phreesia

A number of large investors have recently made changes to their positions in PHR. Federated Hermes Inc. purchased a new position in shares of Phreesia during the 3rd quarter valued at about $32,000. Asset Management One Co. Ltd. purchased a new stake in Phreesia in the 3rd quarter worth approximately $45,000. KBC Group NV raised its stake in Phreesia by 83.4% during the 4th quarter. KBC Group NV now owns 3,449 shares of the company’s stock worth $58,000 after acquiring an additional 1,568 shares during the period. State of Alaska Department of Revenue bought a new stake in Phreesia during the 3rd quarter worth approximately $83,000. Finally, Farther Finance Advisors LLC lifted its holdings in Phreesia by 9,375.0% during the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock valued at $86,000 after purchasing an additional 3,000 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.